中外製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/02/23 | 3,780 | 3,905 | 3,660 | 3,900 | +10 | +0.3% | 2,637,000 |
2017/02/22 | 3,875 | 3,905 | 3,840 | 3,890 | ±0 | ±0% | 996,200 |
2017/02/21 | 3,840 | 3,900 | 3,840 | 3,890 | +50 | +1.3% | 741,900 |
2017/02/20 | 3,850 | 3,875 | 3,825 | 3,840 | -15 | -0.4% | 923,500 |
2017/02/17 | 3,805 | 3,870 | 3,780 | 3,855 | +5 | +0.1% | 1,141,500 |
2017/02/16 | 3,875 | 3,895 | 3,830 | 3,850 | +45 | +1.2% | 1,279,400 |
2017/02/15 | 3,870 | 3,895 | 3,800 | 3,805 | +40 | +1.1% | 978,000 |
2017/02/14 | 3,810 | 3,810 | 3,760 | 3,765 | -60 | -1.6% | 1,054,600 |
2017/02/13 | 3,795 | 3,885 | 3,795 | 3,825 | +45 | +1.2% | 1,256,100 |
2017/02/10 | 3,755 | 3,800 | 3,740 | 3,780 | +95 | +2.6% | 1,379,600 |
2017/02/09 | 3,660 | 3,705 | 3,645 | 3,685 | ±0 | ±0% | 775,800 |
2017/02/08 | 3,680 | 3,710 | 3,670 | 3,685 | +5 | +0.1% | 565,400 |
2017/02/07 | 3,685 | 3,710 | 3,670 | 3,680 | -35 | -0.9% | 716,300 |
2017/02/06 | 3,760 | 3,775 | 3,670 | 3,715 | -15 | -0.4% | 861,000 |
2017/02/03 | 3,690 | 3,755 | 3,665 | 3,730 | +25 | +0.7% | 1,729,500 |
2017/02/02 | 3,615 | 3,810 | 3,605 | 3,705 | +300 | +8.8% | 3,775,000 |
2017/02/01 | 3,355 | 3,445 | 3,300 | 3,405 | +105 | +3.2% | 1,475,600 |
2017/01/31 | 3,325 | 3,350 | 3,280 | 3,300 | -45 | -1.3% | 1,174,000 |
2017/01/30 | 3,360 | 3,360 | 3,310 | 3,345 | -30 | -0.9% | 1,088,800 |
2017/01/27 | 3,385 | 3,405 | 3,355 | 3,375 | ±0 | ±0% | 1,039,900 |
2017/01/26 | 3,335 | 3,385 | 3,325 | 3,375 | +40 | +1.2% | 1,131,500 |
2017/01/25 | 3,315 | 3,350 | 3,305 | 3,335 | +10 | +0.3% | 781,000 |
2017/01/24 | 3,335 | 3,375 | 3,315 | 3,325 | -25 | -0.7% | 1,048,900 |
2017/01/23 | 3,370 | 3,385 | 3,340 | 3,350 | -60 | -1.8% | 1,162,200 |
2017/01/20 | 3,390 | 3,430 | 3,380 | 3,410 | -5 | -0.1% | 810,900 |
2017/01/19 | 3,400 | 3,445 | 3,400 | 3,415 | +20 | +0.6% | 901,700 |
2017/01/18 | 3,400 | 3,405 | 3,360 | 3,395 | -10 | -0.3% | 922,300 |
2017/01/17 | 3,460 | 3,460 | 3,400 | 3,405 | -30 | -0.9% | 837,600 |
2017/01/16 | 3,435 | 3,460 | 3,410 | 3,435 | -15 | -0.4% | 801,600 |
2017/01/13 | 3,405 | 3,465 | 3,395 | 3,450 | +55 | +1.6% | 1,101,400 |
2017/01/12 | 3,460 | 3,460 | 3,385 | 3,395 | -120 | -3.4% | 1,322,400 |
2017/01/11 | 3,505 | 3,530 | 3,475 | 3,515 | +25 | +0.7% | 1,015,800 |
2017/01/10 | 3,505 | 3,560 | 3,480 | 3,490 | +15 | +0.4% | 1,251,900 |
2017/01/06 | 3,465 | 3,495 | 3,455 | 3,475 | +60 | +1.8% | 1,215,100 |
2017/01/05 | 3,395 | 3,455 | 3,395 | 3,415 | +20 | +0.6% | 914,600 |
2017/01/04 | 3,380 | 3,410 | 3,345 | 3,395 | +40 | +1.2% | 1,125,500 |
2016/12/30 | 3,340 | 3,365 | 3,320 | 3,355 | -5 | -0.1% | 729,600 |
2016/12/29 | 3,385 | 3,410 | 3,350 | 3,360 | +5 | +0.1% | 1,060,800 |
2016/12/28 | 3,380 | 3,385 | 3,350 | 3,355 | -95 | -2.8% | 847,900 |
2016/12/27 | 3,500 | 3,515 | 3,440 | 3,450 | -10 | -0.3% | 1,752,900 |
2016/12/26 | 3,400 | 3,465 | 3,330 | 3,460 | +170 | +5.2% | 1,685,200 |
2016/12/22 | 3,320 | 3,330 | 3,275 | 3,290 | -35 | -1.1% | 912,600 |
2016/12/21 | 3,395 | 3,395 | 3,310 | 3,325 | -60 | -1.8% | 1,350,100 |
2016/12/20 | 3,305 | 3,390 | 3,300 | 3,385 | +70 | +2.1% | 1,316,700 |
2016/12/19 | 3,280 | 3,325 | 3,280 | 3,315 | +35 | +1.1% | 683,400 |
2016/12/16 | 3,275 | 3,295 | 3,260 | 3,280 | +15 | +0.5% | 1,174,600 |
2016/12/15 | 3,265 | 3,285 | 3,230 | 3,265 | -5 | -0.2% | 1,180,700 |
2016/12/14 | 3,300 | 3,315 | 3,255 | 3,270 | -25 | -0.8% | 1,090,000 |
2016/12/13 | 3,205 | 3,300 | 3,200 | 3,295 | +110 | +3.5% | 1,388,600 |
2016/12/12 | 3,150 | 3,210 | 3,125 | 3,185 | +90 | +2.9% | 1,776,100 |
2001~
2050
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「中外薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
中外薬 | 862,000円 | +1.7% | +5.0% | 2.90% | 34.60倍 | 7.46倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
第一三共 | 370,200円 | +6.0% | +4.0% | 2.11% | 22.98倍 | 4.25倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
武 田 | 441,900円 | +7.7% | +206.9% | 4.44% | 59.10倍 | 1.00倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
大塚HD | 769,700円 | +2.2% | +10.2% | 1.56% | 14.78倍 | 1.49倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 145,800円 | +0.9% | +380.2% | 5.35% | 20.08倍 | 1.72倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム